SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

402 hedge funds and large institutions have $9.38B invested in Sarepta Therapeutics in 2023 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 150 increasing their positions, 125 reducing their positions, and 78 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
402
Holders Change
-21
Holders Change %
-4.96%
% of All Funds
6.34%
Holding in Top 10
7
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-41.67%
% of All Funds
0.11%
New
59
Increased
150
Reduced
125
Closed
78
Calls
$276M
Puts
$402M
Net Calls
-$126M
Net Calls Change
-$148M

Top Buyers

1
ACA
Avoro Capital Advisors
New York
$530M
2
Wellington Management Group
Wellington Management Group
Massachusetts
$441M
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$504M
4
EC
EcoR1 Capital
California
$419M
5
Citadel Advisors
Citadel Advisors
Florida
$102M

Top Sellers

1
Sands Capital Management
Sands Capital Management
Virginia
$0
2
Fidelity Investments
Fidelity Investments
Massachusetts
$207M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
$31.5M
4
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
$6.69M
5
BG
Bellevue Group
Switzerland
$22.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
SC
476
Schubert & Co
Texas
– -$414 -3 Closed
TWA
477
TCI Wealth Advisors
Arizona
– -$276 -2 Closed
TFM
478
TFC Financial Management
Massachusetts
– -$276 -2 Closed
DI
479
Disciplined Investments
Oklahoma
– -$276 -2 Closed
VFA
480
Values First Advisors
Tennessee
– -$87 -1 Closed
Man Group
481
Man Group
United Kingdom
– -$216K – –
16 17 18 19
20